NeuroSense Therapeutics (H1Z.F) Q2 2025 Earnings

7AprConfirmed
Q1 1
Q2 2025
-0.14
-0.1
-0.07
-0.04

Details

Expected EPS
-0.1373865
Actual EPS
-0.0366364
Surprise EPS
0.1
Surprise Percent
+73.33%

Description

NeuroSense Therapeutics (H1Z.F) has reported earnings of -0.0366364 per share for Q2 2025.

0 Comments

Share your thoughts